Adds xylazine to the list of Schedule III controlled substances in Missouri.
Missouri HB1881 adds xylazine to the list of Schedule III controlled substances. This bill specifies that xylazine is subject to the same regulations as other Schedule III substances, including restrictions on manufacturing, distribution, and use. Exemptions are provided for certain uses of xylazine in veterinary medicine, including approved animal drugs and investigational uses. The bill also outlines specific conditions under which xylazine can be used in pharmaceutical compounding by licensed pharmacists or veterinarians.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.